Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof (2010)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 61/232,603, filed Aug 10, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,252,812 | Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof In force · High confidence UsedRemaining | Biosplice Therapeutics, Inc. | In force | High confidence | ||
| US 8,703,794 | Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof In force · High confidence | Biosplice Therapeutics, Inc. | In force | High confidence | ||
| US 9,090,613 | Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof In force · High confidence | Biosplice Therapeutics, Inc. | In force | High confidence | ||
| US 9,381,192 | Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof In force · High confidence | Biosplice Therapeutics, Inc. | In force | High confidence | ||
| US 9,763,927 | Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof In force · High confidence | Biosplice Therapeutics, Inc. | In force | High confidence | ||
| US 8,822,478 | Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof In force · High confidence | Biosplice Therapeutics, Inc. | In force | High confidence | ||
| US 8,604,052 | Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof Lapsed Dec 10, 2025 on the fee record High confidence | Biosplice Therapeutics, Inc. | Lapsed Dec 10, 2025 on the fee record | High confidence | ||
| US 10,016,406 | Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof Lapsed Jul 10, 2026 on the fee record Medium confidence | Biosplice Therapeutics, Inc. | Lapsed Jul 10, 2026 on the fee record | Medium confidence |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Biosplice Therapeutics, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.